Portage Biotech Rebrands as AlphaTON Capital and Introduces TON Digital Asset Treasury
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 03 2025
0mins
Should l Buy ?
Company Announcement: AlphaTON Capital, previously known as Portage Biotech, is set to acquire approximately $100M in TON tokens and create a digital asset treasury company aimed at supporting Telegram's ecosystem, which boasts over a billion monthly active users.
Strategic Vision: The company aims to enhance open-source, decentralized applications and infrastructure while providing shareholders with exposure to the rapidly growing digital asset market, as highlighted by CEO Enzo Villani's comments on the convergence of traditional finance and blockchain technology.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
